An Approach Based on Advantages over Conventional System

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 1

Abstract

The convenience of administration and improved patient compliance are important in the design of oral drug delivery system which remains the preferred route of drug delivery inspite of various disadvantages. Oral delivery is at this time the gold standard in the drug manufacturing where it is considered as the safest, most convenient and greatest economical method of drug delivery. This is seen to affect about 35% of the general population and associated with a number of circumstances like Parkinsonism, mental disability, motion sickness, unconsciousness, unavailability of the water etc. To overcome such difficulties, mouth dissolving tablets have been developed. Some tablets are designed to dissolve in saliva remarkably fast, within a few seconds, and are true fast-dissolving tablets. One such problem can be solved in the novel drug delivery system by formulating “mouth dissolving tablets” [MDTs] which disintegrates or dissolves rapidly without water within few seconds in the mouth due to the action of superdisintegrant or maximizing pore structure in the formulation. FDT technologies based on lyophilization, molding, sublimation, and compaction, as well as approaches to enhancing the FDT properties, such as spray drying, moisture treatment, sintering, and use of sugar-based disintegrants are applicable. The aim of this review article is to give an overview of advantages of Fast-disintegrating tablets over conventional system.

Authors and Affiliations

Bhupendra Singh Chauhan*| Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan-302022, India., Lalit Singh Chauhan| Department of Pharmaceutics, Mohanlal Sukhadia University, Udaipur, Rajasthan, India., Arindam Chatterjee| Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan-302022, India., Niraj| Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan-302022, India., Shweta Pandey| Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan-302022, India., Uttam Singh Baghel| Department of Pharmaceutical Chemistry, Khalsa College of Pharmacy, Amritsar, Punjab, India

Keywords

Related Articles

NEURAL MODULATION OF INFLAMMATION

Background: In the present situation of emerging cases of drug allergies, auto-immune disorders and adverse reactions to anti-inflammatory drugs, there is a need to find an alternative for handling abnormal immune statu...

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MEFENAMIC ACID USING HYDROPHOBIC POLYMERS

Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It has a dose of 250 mg 4 times daily. It has a very short half life of 2 hours and thus controlling the release wou...

Nanoencapsulation system for delivery of protein and peptide-A review

Various nanopaticulate systems are used for the nanoenapsulation of proteins and peptides for improving peptide drug accumulation inside the target site. Due to less stability of proteins; they get readily degraded the...

OPTIMIZATION OF RHAMNOLIPID BIOSURFACTNT PRODUCTION BY STREPTOMYCES MATENSIS (NBRC 12889T) USING PLACKETT-BURMAN DESIGN

Surfactants produced by microorganisms are known as biosurfactants. Biosurfactants are becoming important biotechnology products for industrial and medical applications due to their specific modes of action, low toxicity...

Breath analysis as a diagnostic tool for lung cancer

The early diagnosis of lung cancer is key to effectively treating this common and deadly disease. In this review we consider whether non-invasive breath-based detection of volatile biomarkers offers a means to screen pop...

Download PDF file
  • EP ID EP1599
  • DOI -
  • Views 420
  • Downloads 25

How To Cite

Bhupendra Singh Chauhan*, Lalit Singh Chauhan, Arindam Chatterjee, Niraj, Shweta Pandey, Uttam Singh Baghel (2013). An Approach Based on Advantages over Conventional System. Journal of Biomedical and Pharmaceutical Research, 2(1), 41-51. https://europub.co.uk/articles/-A-1599